워싱턴의 주요우울장애 임상 시험
주요우울장애 관련 연구 19개가 워싱턴 내 여러 지역에서 참여자를 모집하고 있습니다.
워싱턴의 도시
공식 연구 텍스트(영어)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
피험자 모집 중3상
18세 ~ 85세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07065240A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07412756Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06559306A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07573176Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Core Clinical Research, Everett
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07226661Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07226232A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07300969Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06830044Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
피험자 모집 중
18세 ~ 65세 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT06093906A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT07276997Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
피험자 모집 중3상
18세 이상 · 모든 성별 · 2025. 10. 29. 업데이트됨 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
피험자 모집 중4상
18세 ~ 65세 · 모든 성별 · 2025. 1. 23. 업데이트됨 · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
피험자 모집 중
18세 ~ 64세 · 모든 성별 · 2024. 9. 19. 업데이트됨 · NCT06005194ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.